Mumbai: Out-of-favour Indian cricketer Yusuf Pathan was ousted from the recently concluded Ranji Trophy 2017-18 season after the Board of Control for Cricket in India (BCCI) told the Baroda Cricket Association not to pick the all-rounder. This was after Pathan tested positive for Terbutaline, a banned substance during the tournament last year.
It is learnt that Pathan consumed the medicine, named Brozeet, since he was feeling unwell and the medicine contained Terbutaline.
Athletes need to apply for a Therapeutic Use Exemption (TUE) to consume particular medications. However, in this case, Pathan consumed the banned substance without proper authorisation. Nor he or his team doctor took the prior permission before using the drug.
“There was a substance which was in the medicine which falls under the banned list. He took that particular medicine on the advice of the team doctor. He was not aware that the medicine he took had something which was banned,” the source told The Indian Express.
Terbutaline is an adrenergic receptor agonist which is used as an inhaler when people suffer from breathing problems or medical conditions such as asthma.
The 35-year-old last represented Baroda during October 2017 versus Andhra Pradesh in which he scored only four runs and went wicketless. Pathan is now the second cricketer to be tested positive for a banned substance after Delhi bowler Pradeep Sangwan was handed an 18-month ban in 2013.
Pathan has so far featured in 57 ODIs and 22 T20 Internationals for the Men in Blue, with his last appearance coming against South Africa in 2012. Despite being discarded from national duty, Pathan is a popular figure in the Indian Premier League (IPL) having won two trophies with franchise Kolkata Knight Riders (KKR).